Can GLP-1 receptor agonists improve crude outcomes associated with heart failure? A meta-analysis of randomized controlled trials comprising 78,806 patients

被引：0
|
作者：
Kumric, M. Marko [1 ]
Urlic, H. [1 ]
Kurir, T. Ticinovic [2 ]
Vilovic, M. [1 ]
Glavas, D. [2 ]
Duplancic, D. [2 ]
Bozic, J. [1 ]
机构：
[1] Univ Split, Sch Med, Split, Croatia
[2] Univ Hosp Ctr Split, Split, Croatia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2024年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：313 / 313
页数：1
相关论文
共 50 条
  • [21] Cardiovascular safety of GLP-1 receptor agonists for diabetes patients with high cardiovascular risk: A meta-analysis of cardiovascular outcomes trials
    Wang, Qian
    Liu, Lu
    Gao, Ling
    Li, Qiu
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2018, 143 : 34 - 42
  • [22] Effects of glucagon-like peptide-1 receptor agonists on patients with heart failure: a meta-analysis of randomized controlled trials
    Obata, Shota
    Miyamoto, Yoshihisa
    Slipczuk, Leandro
    Takagi, Hisato
    Kuno, Toshiki
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (02) : 132 - 137
  • [23] GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials
    Tsapas, Apostolos
    Karagiannis, Thomas
    Avgerinos, Ioannis
    Liakos, Aris
    Bekiari, Eleni
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 177
  • [24] Efficacy and safety of GLP-1 agonists in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials
    Messak, Mark
    Abdelmageed, Ahmed
    Senbel, Abdelrahman A.
    Khattab, Youssef A.
    Mandour, Youssef
    Shaker, Omar
    Rehan, Ahmed Hamed
    Oransa, Samir
    Nasr, Mohamed
    Shabeeb, Abdullah Emad
    Rezq, Ziyad
    Hossam, Fares
    Abouelmagd, Moaz Elsayed
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [25] GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials
    Jia, Xiaoming
    Alam, Mahboob
    Ye, Yumei
    Bajaj, Mandeep
    Birnbaum, Yochai
    CARDIOVASCULAR DRUGS AND THERAPY, 2018, 32 (01) : 65 - 72
  • [26] GLP-1 Receptor Agonists and Cardiovascular Disease: a Meta-Analysis of Recent Cardiac Outcome Trials
    Xiaoming Jia
    Mahboob Alam
    Yumei Ye
    Mandeep Bajaj
    Yochai Birnbaum
    Cardiovascular Drugs and Therapy, 2018, 32 : 65 - 72
  • [27] GLP-1 receptor agonists and HBA1c target of <7% in type 2 diabetes: meta-analysis of randomized controlled trials
    Esposito, K.
    Mosca, C.
    Brancario, C.
    Chiodini, P.
    Ceriello, A.
    Giugliano, D.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (08) : 1519 - 1528
  • [28] ASSOCIATION OF GLP-1 AGONISTS WITH ARRHYTHMIAS AND SUDDEN CARDIAC DEATH IN PATIENTS WITH TYPE 2 DIABETES: A META-ANALYSIS OF 27 RANDOMIZED CONTROLLED TRIALS
    Al-Sadawi, Mohammed
    Aslam, Faisal
    Aleem, Saadat
    Alsadaoee, Maryam
    Stevens, Gregg Alexander
    Singh, Abhijeet
    Almasry, Ibrahim O.
    Rashba, Eric J.
    Fan, Roger
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1525 - 1525
  • [29] Angiotensin receptor Blockers in heart failure: Meta-analysis of randomized controlled trials
    Jong, P
    Demers, C
    McKelvie, RS
    Liu, PP
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (03) : 463 - 470
  • [30] Angiotensin receptor blockers in heart failure: Meta-analysis of randomized controlled trials
    Jong, P
    Demers, C
    McKelvie, RS
    Liu, PP
    CIRCULATION, 2001, 104 (17) : 596 - 596
12345